UCSF Medical Center, Mission Bay
Welcome,         Profile    Billing    Logout  
 3 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Carroll, Peter R
MIRROR, NCT06074510: PYLARIFY® PET/CT or PET/MRI in Men with Favorable Intermediate Risk (FIR) Prostate Cancer

Recruiting
4
274
US
Piflufolastat F 18 Intravenous Solution [PYLARIFY], PYLARIFY, 18F-DCFPyL
Lantheus Medical Imaging
Prostate Cancer
11/26
11/26
NCT04976257: Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

Completed
1
5
US
Angiogram, Catheterization, Gallium Ga-labeled PSMA-11, 68Ga-PSMA-11, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging
Ryan Kohlbrenner, MD, Radiological Society of North America
Prostate Adenocarcinoma, Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
03/23
03/23
PASS, NCT00756665: Prostate Active Surveillance Study

Recruiting
N/A
3000
Canada, US
University of Washington, Canary Foundation, Early Detection Research Network
Prostatic Neoplasms
09/29
09/32
Prostate 8-II, NCT03999151: Diet and Exercise Interventions Among Men With Prostate Cancer

Active, not recruiting
N/A
204
US
Exercise and Diet
University of California, San Francisco, National Cancer Institute (NCI)
Prostate Cancer
08/28
08/28
Tenggara, Imelda
MIRROR, NCT06074510: PYLARIFY® PET/CT or PET/MRI in Men with Favorable Intermediate Risk (FIR) Prostate Cancer

Recruiting
4
274
US
Piflufolastat F 18 Intravenous Solution [PYLARIFY], PYLARIFY, 18F-DCFPyL
Lantheus Medical Imaging
Prostate Cancer
11/26
11/26
NCT03976843: Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Active, not recruiting
2
175
US
18F-DCFPyL
National Cancer Institute (NCI)
Prostate Cancer
08/25
08/25
VAPOR 2, NCT05683691: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

Active, not recruiting
N/A
400
US
Vanquish System
Francis Medical Inc.
Prostate Cancer
04/27
04/29
Prostate 8-II, NCT03999151: Diet and Exercise Interventions Among Men With Prostate Cancer

Active, not recruiting
N/A
204
US
Exercise and Diet
University of California, San Francisco, National Cancer Institute (NCI)
Prostate Cancer
08/28
08/28

Download Options